VR Logo

Bausch Health Companies Inc. (BHC) download report


Healthcare | Drugs & Pharma

Bausch Health Companies Inc. (BHC) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology.

IPO Date: 29-Mar-1994

CEO & Director: Mr. Thomas J. Appio

U.S. Pres of Pharma Bus.: Mr. Robert A. Spurr

Listing: NYSE: BHC

Country: Canada

Headquarters: Laval, QC

Website: https://www.bauschhealth.com

Key Facts

Market cap: $2,673.10 Mln

Revenue (TTM): $8,325.00 Mln

Earnings (TTM): $-407.00 Mln

Cash: $1,249.00 Mln

Total Debt: $23,168.00 Mln

Insider's Holding: 2.87%

Liquidity: Low

52 Week range: $6.89 - 30.30

Shares outstanding: 361,480,000

10 Years Aggregate:

  • CFO: $16,109.64 Mln
  • EBITDA: $21,463.32 Mln
  • Net Profit: $-7,809.37 Mln

Stock Performance

Time Period Bausch Health Companies (BHC) S&P BSE Healthcare S&P Small-Cap 600
YTD-68.31-17.32-17.79
1 month-10.62-4.56-2.72
3 months-62.92-10.61-12.17
1 Year-69.91-12.90-15.82
3 Years-28.3819.537.14
5 Years-11.159.106.20
10 Years-15.4012.4410.33
As on 24-Jun-2022
Year Bausch Health Companies (BHC) S&P Small-Cap 600 S&P BSE Healthcare
202132.7425.2720.87
2020-30.489.5761.45
201961.9920.86-3.55
2018-11.06-9.70-5.89
201743.1111.730.49
2016-85.7224.74-12.88
2015-28.97-3.3615.06